263
Views
170
CrossRef citations to date
0
Altmetric
Research Article

Environmental Endocrine Modulators and Human Health: An Assessment of the Biological Evidence

, , , , , & show all
Pages 109-227 | Published online: 29 Sep 2008

References

  • Greenspan, F. S. and Baxter, J. D., Basic and Clinical Endocrinology, 4th ed., Appleton and Lange, Norwalk, CT, 1994.
  • Barnes, S., Peterson, G., Grubbs, C., and Setchell, K., Potential role of dietary isoflavones in the prevention of cancer, in Diet and Cancer: Markers, Prevention and Treatment, Jacobs, M. M., Ed., Plenum Press, New York, 1994, 135.
  • Akiyama, T., Ishida, J., Nakagava, S., Ogawara, S., Watanabe, S., Itoh, N., Shiyba, M., and Fukami, Y., Genistein, a specific inhibitor of tyrosine-specific pro- tein kinases, J. Biol. Chem., 262, 5592, 1987.
  • Markowits, J., Couprie, J., Fosse, P., Saucier, J. M., Perre, J., Linassier, C., Larsen, A. K., Lepecq, J. B., and Jacque- minsablon, A., Inhibitory effects of the tyrosine kinase inhibitor genistein on mam- malian DNA topoisomerase II, Can. Res., 49, 5111, 1989.
  • Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., and Schweigerer, L., Genistein, a di- etary-derived inhibitor of in vitro angio- genesis, Proc. Natl. Acad. Sci., 90, 2690, 1993.
  • Kelce, W. R., Monosson, E., and Gamcsik, M. P., Environmental hormone disruptors: Evidence that vinclozolin de- velopmental toxicity is mediated by antiandrogenic metabolites, Toxicol. Appl. Pharmacol, 126, 276, 1994.
  • National Wildlife Federation, Hormone Copycats, Great Lakes Natural Resource Center, Ann Arbor, MI, 1994.
  • Berne, R. M. and Levy, M. N., Physiol- ogy, 3rd ed., C.V. Mosby, St. Louis, 1993, 1071.
  • Verdeal, K. and Ryan, D. S., Naturally- occurring estrogens in plant foodstuffs — A review, J. Food Protect., 42, 577, 1979.
  • McLachlan, J. A., Rodent models for peri- natal exposure to diethylstilbestrol and their relation to human disease in the male, cited in: Herbst, A. L. and Bern, H. A. Eds., Developmental Effects of Diethylstilbestrol in Pregnancy, Thieme-Stratton, New York, 1981, 148
  • Soto, A. M., Lin, T-M., Justicia, H., Silvia, R. M., and Sonnenschein, C., An “in culture” bioassay to assess the estrogenicity of xenobiotics, cited in: Colborn, T. and Clement, C., Eds., Chemically Induced Alterations in Sexual Development: The Wildlife/Human Connection, Princeton Scientific Publishing, Princeton, NJ, 1992, 295.
  • Soto, A. M., Chung, K. L., and Sonnen- shein, C., The pesticides endosulfan, tox- aphene, and dieldrin have estrogenic ef- fects on human estrogen-sensitive cells, Environ. Health Perspect., 102, 380, 1994.
  • Gaido, K. W., Leonard, L. S., Lovell, S., Gould, J. C., Babai, D., Portier, C. J., and McDonnell, D. P., Evaluation of chemicals with endocrine modulating ac- tivity in a yeast-based steroid hormone re- ceptor gene transcription assay, Tox. Appl. Pharmacol., 143, 205, 1997.
  • Arnold, S.F., Klotz, D. M., Collins, B. M., Vonier, P. M., Guillette, L. J., and McLachlan, J. A., Synergistic activation of estrogen receptor with combinationa of environmental chemicals, Science, 272, 1489, 1996.
  • Ramamoorthy, K., Wang, F., Chen, I.- C., Safe, S., Norris, J. D., McDonnell, D. P., Gaido, K. W., Bocchinfuso, W. P., and Korach, K. S., Potency of combined estrogenic pesticides, Science, 275, 405, 1997a.
  • Ashby, J., Lefevre, P. A., Odum, J., Har- ris, C. A., Routledge, E. J., and Sumpter,J. P., Synergy between synthetic oestro- gens? Nature, 385, 494, 1997.
  • Ramamoorthy, K., Wang, F., Chen, I.-C., Norris, J. D., McDonnell, D. P., Leonard,L. S., Gaido, K. W., Bocchinfuso, W. P., Korach, K. S., and Safe, S., Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen re- ceptor assays: No apparent synergism, Endocrinology, 138, 1520, 1997b.
  • McLachlan, J., Synergistic effect of envi- ronmental estrogen: Report withdrawn. Science, 277, 462, 1997.
  • Newbold, R. R., Bullock, B. C., and McLachlan, J. A., Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal car- cinogenesis, Cancer Res., 50, 7677, 1990.
  • Newbold, R. R. and Bullock, B. C., Le- sions of the rete testis in mice exposed prenatally to diethylstilbestrol, Cancer Res., 45, 5145, 1985a.
  • Newbold, R. R. and Bullock, B. C., Pro- gressive proliferative changes in the ovi- duct of mice following developmental ex- posure to diethylstilbestrol, Teratogenesis Carcinog. Mutagen., 5, 473, 1985b.
  • McLachlan, J., Newbold, R., and Bul- lock, B., Reproductive tract lesions in male mice exposed prenatally to diethylstil- bestrol, Science, 190, 991, 1975.
  • Newbold, R. R., Gender-related behavior in women exposed prenatally to diethyl- stilbestrol, Environ. Health Perspect., 101, 208, 1993.
  • Newbold, R. R., Cellular and molecualr effects of developmental exposure to di- ethylstilbestrol: Implications for other en- vironmental estrogens, Environ. Health Perspect., 103, 83, 1995.
  • Miller, R. K., Perinatal toxicology: Its rec- ognition and fundamentals, Am. J. Ind. Med., 4, 205, 1983.
  • Hogan, M. D., Newbold, R. R., and McLachlan, J. A., Extrapolation of terato- genic responses observed in laboratory animals to humans: DES as an illustrative example, cited in: J. A. McLachlan, J. A., Pratt, R. M., and Markert, C. L., Eds., De- velopmental Toxicology: Mechanisms and Risks, Banbury Report 26, Cold Spring Harbor Laboratory, Cold Spring Harbor, 1987, 257.
  • Greene, R. R., Burrill, M. W., and Ivy, A. C., Experimental intersexuality, Am. J. Anat., 67, 305, 1940.
  • Agency for Toxic Substances and Dis- ease Registry (ATSDR), Toxicological Profile for 4,-DDT, 4,4-DDE, 4,4-DDD, United States Department of Health and Human Services, Washington, D. C., 1993a.
  • Dieckmann, W. J. and Davis, M. E., Does the administration of diethylstilbestrol dur- ing pregnancy have therapeutic value? Am. J. Obstet. Gynecol., 66, 1062, 1953.
  • Stillman, R. J., In utero exposure to dieth- ylstilbestrol: Adverse effects on the repro- ductive tract and reproductive performance in male and female offspring, Am. J. Obstet. Gynecol., 142, 905, 1982.
  • Giusti, R. M., Iwamoto, K., and Hatch,E. E., Diethylstilbestrol revisited: A re- view of the long-term health effects, Ann. Intern. Med., 122, 778, 1995.
  • Herbst, A. L., Ulfelden, H., and Poskan- zer, D. C., Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women, N. Engl. J. Med., 284, 878, 1971.
  • Bibbo, M. and Gill, W. B., Follow-up study of male and female offspring of DES- exposed mothers. Obstet. Gynecol., 49, 1, 1977.
  • Whitehead, E. D. and Leiter, E., Genital abnormalities and abnormal semen analy- sis in male patients exposed to diethylstil- bestrol in utero, J. Urol., 125, 47, 1981.
  • Henderson, B. E., Benton, B., and Cosgrove, M., Urogenital tract abnormali- ties in sons of women treated with diethyl- stilbestrol, Pediatrics, 58, 505, 1976.
  • Herbst, A. L., Kurman, R. J., and Scully,R. E., Vaginal and cervical abnormalities after exposure to stilbestrol in utero, Obstet. Gynelcol., 40, 287, 1972.
  • Herbst, A. L., Poskanzer, D. C., and Robboy, S. J., Prenatal exposure to stil- bestrol: A prospective companion to ex- posed female offspring with unexposed controls, N. Engl. J. Med., 292, 334, 1975.
  • Herbst, A. L. and Hubby, M. M., Repro- ductive and gynecologic surgical experi- ence in diethylstilbestrol-exposed daugh- ters, Am. J. Obstet. Gynecol., 141, 1019, 1981.
  • Leary, F. J., Resseguie, L. J., Kurland,L. T., O’Brien, P.C., Emslander, R.F., and Noller, K.L., Males exposed in utero to diethylstilbestrol, J. Amer. Med. Assoc., 252, 2984, 1984.
  • Hadjimichael, O. C. and Meigs, J. W., Cancer risk among women exposed to ex- ogenous estrogens during pregnancy, J. Natl. Cancer Inst., 73, 831, 1984.
  • Labarthe, D., Adam, E., Noller, K. L., O’Brien, P. C., Robboy, S. J., Tilley, B. C., Townsend, D., Barnes, A. B., Kauf- man, R. H., Decker, D. G., Fish, C. R., Herbst, A. L., Gundersen, J., and Kurland, L.T., Design and preliminary observations of the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project, Obstet. Gynecol., 51, 453, 1978.
  • Heinonen, O. P., Diethylstilbestrol in preg- nancy: frequency of exposure and usage patterns, Cancer, 31, 573, 1973.
  • Gill, W. B., Schumacher, G. F. B., and Bibbo, M., Association of diethylstilbestrol exposure in utero with cryptorchidism, tes- ticular hypoplasia and semen abnormali- ties, J. Urol., 122, 36, 1979.
  • Wilcox, A. J., Baird, D. D., Weinberg,C. R., Hornsby, P. P., and Herbst, A. L., Fertility in men exposed prenatally to di- ethylstilbestrol, N. Eng. J. Med, 332, 1411, 1995.
  • Vessey, M. P., Fairweather, D. V., Norman-Smith, B., and Buckley, J., A randomized double-blind controlled trial of the value of stilboestrol therapy during pregnancy: Long-term follow-up of moth- ers and their offspring, Br. J. Obstet. Gynecol., 90, 1007, 1983.
  • Report to the Medical Research Coun- cil, The use of hormones in the manage- ment of pregnancy in diabetics, Lancet, 269, 833, 1955.
  • Ahlborg, U. G., Lipworth, L., Titus- Ernstoff, L., Hsieh, C. C., Hanberg, A., Baron, J., Trichopoulos, D., and Adami,H. O., Organochlorine compounds in rela- tions to breast cancer, endometrial cancer, and endometriosis: An assessment of the biological and epidemilogical evidence, Crit. Rev. Toxicol., 25, 463, 1995.
  • Gellert, R. J., Uterotrophic activity of polychlorinated biphenyls and induction of precocious reproductive aging in neona- tally treated female rats, Environ. Res., 16, 123, 1978.
  • Bitman, J. and Cecil, H. C., Estrogenic activity of DDT analogs and polychlori- nated biphenyls, J. Agr. Food Chem., 18, 1108, 1970.
  • Jansen, H. T., Cooke, P. S., Porcelli, J., Liu, T. C., and Hansen, L. G., Estrogenic and antiestrogenic actions of PCBs in the female rat: In vitro and in vivo studies, Reprod. Toxicol., 7, 237, 1993.
  • Korach, K. S., Sarver, P., Chae, K., McLachlan, J. A., and McKinney, J. D., Estrogen receptor-binding activity of poly- chlorinated hydroxybiphenyls conforma- tionally restricted structural probes, Mol. Pharmacol., 33, 120, 1987.
  • Moore, M., Mustain, M., Daniel, K., Chen, I., Safe, S., Zacharewski, T., Gillesby, B., Joyeuxz, A., and Balaguer, P., Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners iden- tified in human serum, Toxical. Appl. Pharmacol. 142, 160, 160, 1997.
  • Krishnan, V. and Safe, S., Polychlori- nated biphenyls (PCBs), dibenzo-p-diox- ins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships, Toxicol. Appl. Pharmacol., 120, 55, 1993.
  • Sager, D. B., Effect of postnatal exposure to polychlorinated biphenyls on adult male reproductive function, Environ. Res., 31, 76, 1983.
  • Sager, D. B. and Giraud, D. M., Long- term effects on reproductive parameters in female rats after translactational exposure to PCBs, Environ. Res., 66, 52, 1994.
  • Gellert, R. J., Heinrichs, W. L., and Swerdloff, R. S., DDT homologues: Es- trogen-like effects on the vagina, uterus, and pituitary of the rat, Endocrinology, 91, 1095, 1972.
  • Clement, J. G. and Okey, A. B., Estro- genic and antiestrogenic effects of DDT administered in the diet of immature fe- male rats, Can. J. Physiol. Pharmacol., 50, 971, 1972.
  • Duby, R. T., Travis, H. F., and Terrill,C. E., Uterotrophic activity of DDT in rats and mink and its influence on reproduction in the rat, Toxicol. Appl. Pharmacol., 18, 348, 1971.
  • Heinrichs, W. L., Gellert, R. J., Bakke,J. L., and Lawrence, N. L., DDT admin-istered to neonatal rats induces persistent estrus syndrome, Science, 173, 642, 1971.
  • Gellert, R. J., Heinrichs, W. L., and Swerdloff, R., Effects of neonatally-ad- ministered DDT homologs on reproduc- tive function in male and female rats, Neu- roendocrinology, 16, 84, 1974.
  • Gellert, R. J. and Heinrichs, W. L. Ef- fects of DDT homologs administered to female rats during the perinatal period, Biol. Neonate., 26, 283, 1975.
  • Welsh, R. M., Levin, W., and Conney, A.H., Estrogenic action of DDT and its analogs, Tox. Appl. Pharmacol., 14, 358, 1969.
  • Jobling, S., Reynolds, T., White, R., Parker, M. G., and Sumpter, J. P., A variety of environmentally persistent chemi- cals, including some phthalte plasticizers, are weakley estrogenic, Environ. Health Perspect., 103, 582, 1995.
  • White, R., Jobling, S., Hoare, S. A., Sumpter, J. P., and Parker, M. G., Envi- ronmentally persistent alkylphenolic com- pounds are estrogenic, Endocrinology, 135, 175, 1994.
  • Hammond, B., Katzenellenbogen, B. S., Krauthammer and McConnell, J., Es- trogenic activity of the insecticide chlor- decone (kepone) and interaction with uter- ine receptors, Proc. Natl. Acad. Sci., 76, 6641, 1979.
  • United States Environmental Protection Agency (EPA), Health Assessment Docu- ment for 2,3,7,8–Tetrachlorodibenzo-p-di- oxin (TCDD) and Related Compounds, Vol. I, II, III., EPA/600/BP-92/001c, 1994.
  • United States Environmental Protection Agency (EPA), Health Assessment Docu- ment for 2,3,7,8–Tetrachlorodibenzo-p-di- oxin (TCDD) and Related Compounds, Revised Chap. 8, Dose-Response Model- ing, 1997.
  • Walker, M. K., Cook, P. M., Butter- worth, B. C., Zabel, E. W., and Peterson,R. E., Potency of a complex mixture of polychlorinated dibenzo-p-dioxin, dibenzo- furan, and biphenyl congeners compared with 2,3,7,8-tetrachlorodibenzo-p-dioxin in causing fish early life stage mortality, Fund. Appl. Toxicol., 30, 178, 1996.
  • Safe, S. H., Environmental and dietary estrogens and human health — Is there a problem? Environ. Health Perspect., 103, 346, 1995.
  • Burroughs, C. D., Bern, H. A., and Stokstad, E. L. R., Prolonged vaginal cornification and other changes in mice treated neonatally with coumestrol, a plant estrogen, J. Toxicol. Environ. Health, 15, 51, 1985.
  • Kuiper-Goodman, T., Scott, P. M., and Watanabe, H., Risk assessment of the mycotoxin zearalenone, Reg. Toxicol. Pharmacol., 7, 253, 1987.
  • Setchell, K. D. R., Borriello, S. P., Hulme, P., Kirk, D. N., and Axelson, M., Nonste- roidal estrogens of dietary origin: Possible roles in hormone-dependent disease, Amer.J. Clin. Nutrition, 40, 569, 1984.
  • Barrett, J., Phytoestrogens: Friends or foes? Environ. Health Perspect., 104, 478, 1996.
  • Ziegler, R. G., Hoover, R. N., Pike, M. C., Hildesheim, A., Nomura, A. M. Y., West,D. W., Wu-Williams, A. H., Kolonel, L. N., Horn-ross, P. L., Rosenthal, J. F., and Hyer, M. B., Migration patterns and breast cancer risk in Asian-American women, J. Natl. Cancer Inst., 85, 1819, 1993.
  • Messina, M. J., Persky, V., Setchell, K. D. R., and Barnes, S., Soy intake and cancer risk: A review of the in vitro and in vivo data, Nutr. Cancer, 21, 113, 1994.
  • Baird, D. D., Umbach, D. M., Lansdell, L., Hughes, C. L., Setchell, K. D. R., Weinberg, C. R., Haney, A. F., Wilcox, A. J., and McLachlan, J. A., Dietary in- tervention study to assess estrogenicity of dietary soy among postmenopausal women, J. Clin. Endocrinol. Metab. 80, 1685, 1995.
  • Burroughs, C. D., Bern, H. A., and Stokstad, E. L. R., Reproductive tract abnormalities in female mice exposed neo- natally to various doses of coumestrol, J. Toxicol. Environ. Health, 30, 105, 1990.
  • Gray Jr., L. E., Ferrell, J. M., and Ostby,J. S., Alteration of behavioral sex differen- tiation by exposure to estrogenic com- pounds during critical neonatal period: Effects of zearalenone, methoxychlor, and estradiol in hamsters, Toxicol. Appl. Pharmacol., 80, 127, 1985.
  • Kaldas, R. S. and Hughes Jr., C. L., Reproductive and general metabolic effects of phytoestrogens in mammals, Reprod. Toxicol., 3, 81, 1989.
  • Whitten, P. L., Lewis, C., and Naftolin, F., A phytoestrogen diet induces the pre- mature anovulatory syndrome in lactation- ally exposed female rats, Biol. Reprod., 49, 1117, 1993.
  • Gavaler, J. S., Galvao-Teles, A., Monteiro, E., van Thiel, D. H., and Rosenblum, E., Clinical responses to the administration of bourbon phytoestrogens to normal postmenopausal women, Hepa- tology, 14, 87A, 1991.
  • Rosenblum, E. R., Campbell, I. M., van Thiel, D. H., and Gavaler, J. S., Isolation and identification of phytoestrogens from beer, Alcohol. Clin. Exp. Res., 16, 843, 1992.
  • Rosenblum, E. R., Stauber, R. E., Van Thiel, D. H., Campbell, I. M., and Gavaler, J. S., Assessment of the estro- genic activity of phytoestrogens isolated from bourbon and beer, Alcohol. Clin. Exp. Res., 17, 1207, 1993.
  • Schutt, D. A., The effects of plant estro- gens on animal reproduction, Endeavor, 35, 110, 1976.
  • Markaverich, B. M., Webb, B., Densmore,C. L., and Gregory, R. R., Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats, Environ. Health Perspect., 103, 574, 1995.
  • Hughes Jr., C. L., Phytochemical mim- icry of reproductive hormones and modu- lation of herbivore fertility by phyto- estrogens, Environ. Health Perspect., 78, 171, 1988.
  • Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton- Culver, H., Medical hypothesis: Xeno-estrogens as preventable causes of breast cancer, Environ. Health Perspect., 101, 372, 1993.
  • SEER, SEER Cancer Statistics Review: 1973–1990, Miller, B. A., Ries, L. A. G., Hankey, B. F., Kosary, C. L., Harras, A., Devesa, S. S., and Edwards, B. K., Eds., No. 93–2789, National Cancer Institute, National Institutes of Health, Bethesda, MD, 1993.
  • Lipworth, L., Epidemiology of breast can- cer, Eur. J. Cancer Preven., 4, 7, 1995.
  • Houghton, D. L. and Ritter, L., Orga- nochlorine residues and risk of breast can- cer, J. Am. Coll. Toxicol., 14, 71, 1995.
  • Harris, J. R., Lippman M. E., and Veronesi U., Breast cancer, Part 1 of 3, New Engl. J. Med., 327, 319, 1992.
  • Trichopoulos, D., Hypothesis: Does breast cancer originate in utero? Lancet, 335 939, 1990a.
  • Trichopoulos, D., Is breast cancer initi- ated in utero? Editorial, Epidemiol, 1, 95, 1990b.
  • Kelsey, J. L., Breast cancer epidemiology: Summary and future directions. Epid. Rev. 15, 256, 1993.
  • Pollner, F., A holistic approach to breast cancer research, Environ. Health Perspect., 101, 116, 1993.
  • Anon., Risk assessment and religion, Na- ture Genetics, 11, 105, 1995.
  • Willet, W. C., Stampfer, M. J., Colditz, G. A., Rosner, B. A., Hennekens, C. H., and Speizer, F. E., Dietary fat and the risk of breast cancer, N. Engl. J. Med., 316, 22, 1987.
  • Colditz, G. A., Egan, K. M., and Stampfer, M. J., Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies, Am. J. Obstet. Gynecol., 168, 1473, 1993.
  • Mansfield, C. M., A review of the etiol- ogy of breast cancer, J. Nat. Med. Assoc., 85, 217, 1993.
  • Boyd, N. F., Martin, L. J., and Noffel, M., A meta-analysis of studies of dietary fat and breast cancer, Br. J. Cancer, 68, 627, 1993.
  • Yu, H., Harris, R. E., Gao, Y-T., Gao, R., and Wynder, E. L., Comparative epi- demiology of cancer of the colon, rectum, prostate and breast in Shanghai, China vs. the United States, Int. J. Epidemiol., 20, 76, 1991.
  • Thomas, D. B. and Karagas, M. R., Can- cer in first and second generation Ameri- cans, Cancer Res., 47, 5771, 1987.
  • Shimizu, H., Ross, R. K., Bernstein, L., Yatani, R., Henderson, B. E., and Mack,T. M., Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county, Br. J. Cancer, 63, 963, 1991.
  • DeWaard, F. and Trichopoulos, D., A unifying concept of the aetiology of breast cancer, Int. J. Cancer, 41, 666, 1988.
  • Rose, D. P., Goldman, M., and Connolly,J. M., A high-fiber-supplement diet reduces serum estrogen levels in premenopausal women, Am. J. Clin. Nutr., 54, 520, 1991.
  • Adlercreutz, H., Mousavi, Y., and Hockerstedt, K., Diet and breast cancer, Acta. Oncol., 31, 175, 1992.
  • Coward, L., Barnes, N. C., Setchell, K.D. R., and Barnes, S., Genistein, daidzein, and their [beta]-glycoside conjugates: An- titumor isoflavones in soybean foods from American and Asian diets, J. Agricul. Food Chem., 41, 1961, 1993.
  • Longnecker, M. P., Paganini-Hill, A., and Ross R. K., Lifetime alcohol consumption and breast cancer risk among postmeno- pausal women in Los Angeles, Cancer Epidemiol. Biomarkers Prev., 4, 721, 1995.
  • McGregor, H., Land, C. E., and Choi, K., Breast cancer incidence aming atomic bomb survivors, Hiroshima and Nagasaki, 1950–1969, J. Natl. Cancer Inst., 59, 799, 1977.
  • Palmer, B. D. and Palmer, S. K., Vitellogenin induction by xenobiotic es- trogens in the red-eared turtle and African clawed frog, Environ. Health Perspect. Suppl., 103, 19, 1991.
  • Hsieh, C. C and Trichopoulos, D., Breast size, handedness and breast cancer risk, Eur. J. Cancer Clin. Oncol., 27, 131, 1991.
  • Zhang, Z.-F., Vena, J. E., Zielezny, M., Graham, S., Haughey, B. P., Brasure, J., and Marshall, J. R., Occupational expo- sure to extreme temperature and risk of testicular cancer, Arch. Environ. Health, 50, 13, 1995.
  • Kelsey, J. L. and Horn-Ross, P. L., Breast cancer: Magnitude of the problem and de- scriptive epidemiology, Epi. Rev., 15, 7, 1993.
  • Robbins, A. S., Brescianini, S., and Kelsey, J. L., Regional differences in known risk factors and the higher inci- dence of breast cancer in San Francisco, J. Nat. Cancer Inst., 89, 960, 1997.
  • Gilman, A. G., Rall, T. W., Nies, A. S., and Taylor, P., Eds., Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 8th ed. McGraw-Hill, Inc., New York, 1990.
  • Isselbacher, K. J., Braunwald, A. B., Wilson, J. D., Martin, J. B., Fauci, A. S., and Kasper, D. L., Eds., Harrison’s Prin- ciples of Internal Medicine, 13th ed., McGraw-Hill, New York, 1994, 2496.
  • Miller, D. R., Rosenburg, L. Kaufman,D. W., Stolley, P., Warshauer, M. E., and Shapiro, S., Breast cancer before age 45 and oral contraceptive use: New find- ings, Am. J. Epidemiol., 129, 269, 1989.
  • Romieu, I., Berlin, J. A., and Colditz, G., Oral contraceptives and breast cancer, re- view and meta-analysis, Cancer, 66, 2253, 1990.
  • Thomas, E. J., Endometriosis: Still an enigma, Brit. J. Obstet. Gynaecol., 100, 615, 1993.
  • Thomas, B. D., Oral contraceptives and breast cancer: review of the epidemiologic literature, Contraception, 43, 633, 1991.
  • World Health Organization (WHO), Collaborative Study of Neoplasia and Ste- roid Contraceptives—Breast Cancer and Combined Oral Contraceptives: Results From Multinational Study, Brit. J. Cancer, 61,110, 1990.
  • Brinton, L. A., Menopause and the risk of breast cancer, Ann. N. Y. Acad. Sci., 592, 357, 1990.
  • Brinton, L. A. and Schairer, C., Estrogen replacement therapy and breast cancer risk, Epi. Rev. 15, 66, 1993.
  • Buring, J. F., Hennekens, C. H., and Lipnick, R. J., A prospective cohort study of postmenopausal hormone use and risk of breast cancer in U. S. women, Am. J. Epidemiol., 125, 939, 1987.
  • Bergkvist, L., Adami, H. O., and Persson, I., The risk of breast cancer after estrogen and strogen-progestin replacement, N. Engl. J. Med. 321, 293, 1989.
  • Yang, C. P., Daling, J. R., and Band, P. R., Noncontraceptive hormone use and risk of breast cancer, Cancer Causes Control., 3, 475, 1992.
  • Key, T. J. and Pike, M. C., Role of estro- gens and progestgens in the epidemiology and prevention of breast cancer, Eur. J. Clin. Oncol., 24, 29, 1988.
  • Hunt, K., Long-term effects of postmeno- pausal hormone therapy, Br. J. Hosp. Med., X, 450, 1987.
  • Ettinger, B., Friedman, G. D., Bush, T., and Quesenberry, C. P., Reduced mortal- ity associated with long-term postmeno- pausal estrogen therapy, Obstet. Gynecol., 87, 6, 1996.
  • Greenberg, E. R., Barnes, A. B., Resseguie, L., and Barrett, J. A., Breast cancer in mothers given diethylstilbestrol in pregnancy, N. Engl. J. Med., 311, 1393, 1984.
  • Colton, T. and Greenberg, E. R., Breast cancer in mothers prescribed diethylstil- bestrol, J. Amer. Med. Assoc., 269, 2096, 1993.
  • Thompson, J. A. and Janench, D. T., Maternal age at birth and risk of breast cancer in daughters, Epidemiology., 1, 101, 1990.
  • Rothman, K. J., MacMahon, B., and Lin,T. M., Maternal age and birth rank of women with breast cancer, J. Natl. Cancer Inst., 65, 719, 1980.
  • Madigan, M. P., Ziegler, R.G., Benichou, J., Byrne, C., and Hoover, R.N., Propor- tion of breast cancer cases in the United States explained by well-established risk factors, J. Nat. Cancer Inst., 87, 1681, 1995.
  • Brown, N. M. and Lamartiniere, C. A., Xenoestrogens alter mammary gland dif- ferentiation and cell proliferation in the rat, Environ. Health Perspect., 103, 708, 1995.
  • Adami, H. O., Berstrom, R., Lund, E., and Meirik, O., Absence of associations between reproductive variables and the risk of breast cancer in young women in Swe- den and Norway, Brit. J. Cancer, 62, 122, 1990.
  • Yoo, K. Y., Tajima, K., and Kuroishi, T., Independent protective effect of lacta- tion against breast cancer: A case-control study in Japan, Am. J. Epidemiol., 135, 726, 1992.
  • Newcombe, P. A., Storer, B. E., and Longnecker, M. P., Lactation and a re- duced risk of premenopausal breast cancer, N. Engl. J. Med., 330, 81, 1994.
  • Dewailly, E., Ayotte, P., and Brisson, J., Protective effect of breast feeding on breast cancer and body burden of carcinogenic organochlorines, J. Nat. Cancer Inst., 86, 803, 1994.
  • Bradlow, H. L., Davis, D. L., Lin, G., Sepkovic, D., and Tiwari, R., Effects of pesticides on the ratio of 16a/2–hydroxy- estrone: A biologic marker of breast cancer risk, Environ. Health Perspect. Suppl., 103, 147, 1995.
  • Murray, F. J. and Edgren, R. A., A criti- cal review of the “good estrogen/bad estro- gen” hypothesis and breast cancer; A re- view for the Chemical Manufacturers Association, Washington, D. C., January 23, 1995.
  • Kimbrough, R. D., Laboratory and hu- man studies on polychlorinated biphenyls (PCBs) and related compounds, Environ. Health Perspect., 59, 99, 1985.
  • National Cancer Institute (NCI), Bioas- says of DDT, TDE, and p,p-DDE for Pos- sible Carcinogenicity, NTIS #PB-286–367, 1978.
  • Rossi, L., Ravera, M., Repetti, G., and Santi, L., Long-term administration of DDT or phenobarbital-Na in Wistar rats, Int. J. Cancer, 19, 179, 1977.
  • Tomatis, L., Turusov, V., and Day, N.,The effect of long-term exposure to DDT on CF-1 mice, Int. J. Cancer., 10, 489, 1972.
  • Radomski, J. L. and Fiserova-Bergerova, V., The determination of pesticides in tis- sues with the electron capture detector with- out prior clean-up, Ind. Med. Surg., 34, 934, 1965.
  • Cabral, J. R. P. and Hall, R. K., Effects of long term intake of DDT on rats, Tum- origenesis, 68, 11, 1982.
  • Unger, M., Kiaer, H., Blichert-toft, M., Olsen, J., and Clausen, J., Organochlo- rine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diag- nosed patients undergoing breast surgery, Environ. Res., 34, 24, 1984.
  • Falck, F., Ricci, A. and Godbold, J., Pes- ticides and polychlorinated biphenyl resi- dues in human breast lipids and their rela- tion to breast cancer, Arch. Environ. Health, 47, 143, 1992.
  • Mussalo-Rauhamaa, H., Hasanen, E., and Pyysalo, H., Occurrence of beta- hexachlorocyclohexane in breast cancer patients, Cancer, 66, 2124, 1990.
  • Wolff, M. S., Toniolo, P. G., Lee, E. W., Rivera, M., and Dubin, N., Blood levels of organochlorine residues and risk of breast cancer, J. Natl. Cancer Inst., 85, 648, 1993.
  • Krieger, N., Wolff, M. S., and Hiatt, R. A., Breast cancer and serum organochlo- rines: A prospective study among, black, and Asian women, J. Natl. Cancer Inst., 86, 589, 1994.
  • Hunter, D. J., Hankinson, S. E., Laden, F., Colditz, G. A., Manson, J. E., Willett,W. C., Speizer, F. E., and Wolff, M. S., Plasma organochlorine levels and the risk of breast cancer, N. Engl. J. Med. 337, 1253, 1997.
  • International Agency for Research on Cancer (IARC), Cancer Incidence in Five Continents, Waterhouse, J., Muir, C. and Correa, P., Eds., Scientific Pub. No. 120, 1992.
  • van’t Veer, P., Lobbezoo, I. E., Martin- Moreno, J. M., Guallar, E., Gomez- Aracena, J., Kardinaal, A. F. M., Kohlmeier, L., Martin, B. C., Strain, J. J., Thamm, M., van Zoonen, P., Baumann,B. A., Huttunen, J. K., and Kok, F. J., DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study, Brit. Med. J., 315, 81, 1997.
  • Lopez-Carrillo, L., Blair, A., Lopez- Cervantes, M., Cebrian, M., Rueda, C., Reyes, R., Mohar, A., and Bravo, J., Dichlorodiphenyltrichloroethane serum lev- els and breast cancer risk: A case-control study from Mexico, Can. Res. 57, 3728, 1997.
  • Key, T. and Reeves, G., Organochlorines in the environment and breast cancer, Br. Med. J., 308, 1520, 1994.
  • Brown, D. P., Mortality of workers ex- posed to polychlorinated biphenyls — An update, Arch. Environ. Health, 42, 333, 1987.
  • Bertazzi, P. A., Riboldi, L., Pesatori, A., Radice, L., and Zocchetti, C., Cancer mortality of capacitor manufacturing workers, Am. J. Indus. Med., 11, 165, 1987.
  • Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber,D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., Hummel,R. A., and Humiston, C. G., Results of a two year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-di- oxin in rats, Toxicol. Appl. Pharmacol., 46, 279, 1978.
  • Safe, S., Astroff, B., Harris, M., Zacharewski, T., Dickerson, R., Romkes, M., and Biegel, L., 2,3,7,8-tetrachloro- dibenzo-p-dioxin (TCDD) and related com- pounds as antiestrogens: Characterization and mechanism of action, Pharmacol. Toxicol., 69, 400, 1991.
  • Porter, W. P., Green, S. M., Debbink, N. L., and Carlson, I., Groundwater pesti- cides: Ineractive effects of low concentra- tions of carbamates aldicarb and methomyl and the triazine metribuzin on thyroxine and somatotropin levels in white rats, J. Toxicol. Environ. Health, 40, 15, 1993.
  • Holcomb, M. and Safe, S., Inhibition of 7,12–dimethylbenzathracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Cancer Let- ters, 82, 43, 1994.
  • Bertazzi, P. A., Pesatori, A. C., and Consonni, D., Cancer incidence in a popu- lation accidentally exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin, Epidemiology, 4, 398, 1993.
  • Bertazzi, P. A., Pesatori, A. C., and Landi, M.T., Cancer mortality, 1976–1991, in the population exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin, Organo- halogen Compounds, 30, 1996.
  • Mangtani, P., and Booth, M., Epidemiol- ogy of endometriosis, J. Epidemiol. Comm. Health 47, 84, 1993.
  • Sangi-Haghpeykar, H. and Poindexter,A. N., Epidemiology of endometriosis among parous women, Obstet. Gynecol., 85, 983, 1995.
  • Olive, D. L. and Barrie Schwartz, L., Endometriosis, New Engl. J. Med., 328, 1759, 1993.
  • Houston, D. E., Noller, K. L., Melton III,L. J., Selwyn, B. J., and Hardy, R. J., The incidence of pelvic endometriosis among women of reproductive age in Roch- ester, Minnesota, 1970–1979, Am. J. Epidiol., 24, 517, 1979.
  • Wardle, P. G. and Hull, M. G. R., Is endometriosis a disease? Bailliere’s Clin. Obstet. Gynecol., 7, 673, 1993.
  • Moen, M. H., Is mild endometriosis a dis- ease? Why do women develop endometrio- sis and why is it diagnosed? Hum. Reprod., 10, 8, 1995.
  • Sampson, J. A., Peritoneal endometriosis due to the menstrual dissemination of en- dometrial tissue into the peritoneal cavity, Am. J. Obstet. Gynecol., 14, 422, 1927.
  • Sampson, J. A., The development of the implantation theory for the origin of peri- toneal endometriosis, Am. J. Obstet. Gynecol., 40, 549, 1940.
  • Moen, M. H. and Magnus, P., The famil- ial risk of endometriosis, Acta. Obstet. Gynecol. Scand., 72, 560, 1993.
  • Simpson, J. L., Elias, S., and Malinak,L. R., Heritable aspects of endometriosis.II. Genetic studies, Am. J. Obstet. Gynecol. ,141, 327, 1984.
  • Dmowski, W. P., Gebel, H. M., and Braun, D. P., The role of cell-mediated immunity in pathogenesis of endometrio- sis, Acta. Obstet. Gynecol. Scand. Suppl., 159, 7, 1994.
  • Vigano, P., Vercellini, P., di Blasio, A. M., Colombo, A., Candiani, G. B., and Vignali, M., Deficient antiendometrium lymphocyte-mediated cytotoxicity in pa- tients with endometriosis, Fertil. Steril., 56, 894, 1991.
  • Oosterlynck, D. J., Cornillie, F. J., Waer, M., Vandeputte, M., and Koninckx, P. R., Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous en- dometrium, Fertil. Steril., 56, 45, 1991.
  • Tanaka, E., Sendo, F., Kawagoe, S., and Hiroi, M., Decreased natural killer activity in women with endometriosis, in Lymphok- ine-activated killer activity in women with endometriosis, Oosterlynck, D. J., Lacquet, F. A., Waer, M., Koninckx, P. R., Eds., Gynecol. Obstet. Invest., 37, 185, 1992.
  • Kanzaki, H., Wang, H.-S., Kariya, M., and Mori, T., Suppression of natural killer cell activity by sera from patients with en- dometriosis, Am. J. Obstet. Gynecol., 167, 257, 1992.
  • Oosterlynck, D. J., Meuleman, C., Lacquet, F. A., Waer, M., and Koninckx, P. R., Flow cytometry analysis of lympho- cyte subpopulations in peritoneal fluid of women with endometriosis, Am. J. Repro. Immunol., 31, 15, 1994.
  • Wild, R. A., Hirisave, V., Podczaski, E. S., Coulam, C., Shivers, C. A., and Satyaswaroop, P. G., Autoantibodies as- sociated with endometriosis: Can their de- tection predict presence of the disease? Obstet. Gynecol., 77, 927, 1991.
  • Gilmore, S. M., Aksel, S., Hoff, C., and Peterson, R. D., In vitro lymphocyte ac- tivity in women with endometriosis— An altered immune response? Fertil. Steril., 58, 1148, 1992.
  • Gleicher, N., El-Roeiy, A., Confino, E., and Friberg, J., Is endometriosis an au- toimmune disease? Obstet. Gynecol., 70, 115, 1987.
  • El-Roeiy, A., Dmowski, W. P., Gleicher, N., Radwanska, E., Harlow, L., Binor, Z., and Tummon, I., Danazol but not GnRH agonists suppresses autoantibodies in endometriosis, Fertil. Steril., 50, 864, 1988.
  • Grosskinsky, C. M. and Halme, J., En- dometriosis: The host response, Baillieres Clin. Obstet. Gynecol., 7, 701, 1993.
  • Greydanus, D. E. and Mcanarney, E. R., Menstruation and its disorders in adoles- cence, Cur. Prob. Pediatr. ,1, 1982.
  • Strathy, J. H., Molgaard, C. A., Coulam,C. B., and Melton III, L. J., Endometrio- sis and infertility: A laparoscopic study of endometriosis among fertile and infertile women, Fertil. Steril., 38, 667, 1982.
  • Mahmood, T. A. and Templeton, A., Prevalence and genesis of endometriosis, Human Reprod., 6, 544, 1991.
  • Moen, M. H., Endometriosis in women at interval sterilization, Acta. Obstet. Gynecol. Scand., 66, 451, 1987.
  • Vessey, M. P., Villard-Mackintosh, L., and Painter, R., Epidemiology of en- dometriosis in women attending family planning clinics, Brit. Med. J., 306, 182, 1993.
  • Royal College of General Practitioners, Oral contraceptives and health: An interim report from the oral contraceptive study of the Royal College of General Practitio- ners, Pitman Medical Publ., London, 1974.
  • Ramcharan, S., Pellegrin, F. A., Ray, R., and Hsu, J. P., The Walnut Creek contra- ceptive drug study: a rospective study of the side effects of oral contraceptives. Vol III. Nat. Inst. Health, Center for Population Research Mono., Pub. No. 81–564, 1981.
  • Sutton, G., Hormonal aspects of endome- trial cancer, Cur. Opin. Obstet. Gynecol., 2, 69, 1990.
  • Garner, C. H. and Webster, B. W., En- dometriosis, J. Obstet. Gynecol. Neonatal Nurs., 14, 10s, 1985.
  • Karansky, K. J., Endometriosis, J. Amer. Med. Assoc., 57, 267, 1955.
  • Stillman, R. J. and Miller, L. R. C., Di- ethylstilbestrol exposure in utero and en-dometriosis in infertile females, Fertil. Steril., 41, 369, 1984.
  • Muse, K. N. and Wilson, E. A., How does mild endometriosis cause infertility? Fertil. Steril., 38, 145, 1982.
  • Wheeler, J. M., Johnston, B. M., and Malinak, L. R., The relationship of en- dometriosis of spontaneous abortion, Fertil. Steril., 39, 656, 1983.
  • Berger, M. J. and Alper, M. M., Intrac- table primary infertility in women exposed to diethylstilbestrol in utero, Reprod. Med., 31, 231, 1986.
  • Rier, S. E., Martin, D. C., Bowman, R. E., Dmowski, W. P., and Becker, J. L., Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Fund. Appl. Toxicol., 21, 433, 1993.
  • Arnold, D. L., Nera, E. A., Stapley, R., Tolnai, G., Claman, P., Hayward, S., Tryphonas, H., and Bryce, F., Prevalence of endometriosis in rhesus (Macaca mulatta) monkeys ingesting PCB (Aroclor 1254): Review and evaluation, Fund. Appl. Tox., 31, 42, 1996.
  • McCann, T. O. and Myers, R. E., En- dometriosis in rhesus monkeys, Am. J. Obstet. Gynecol., 106, 516, 1970.
  • Hong, R., Taylor, K., and Abonour, R., Immune abnormalities associated with chronic TCDD exposure in Rhesus mon- keys, Chemosphere, 18, 313, 1989.
  • Cummings, A. M., Metcalf, J. L., and Birnbaum, L., Promotion of endometrio- sis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: Time-dose dependence and species comparison, Toxicol. Appl. Pharmacol., 138, 131, 1996.
  • Johnson, K. L., Cummings, A. M., and Birnbaum, L. S., Promotion of en- dometriosis in mice by polychlorinated dibenzo-p-dioxins, dibenzofurans, and bi- phenyls. Environ. Health Perspect. 105, 750, 1997.
  • Allen, J. R., Barsotti, D. A., Van Miller,J. P., Abrahamson, L., and Lalich, J. J., Morphological changes in monkeys con- suming a diet containing low levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin, Food Cosmet. Toxicol., 15, 401, 1977.
  • Barsotti, D. A., Abrahamson, L. J., and Allen, J. R., Hormonal alterations in fe- male rhesus monkeys fed a diet containing 2,3,7,8-tetrachlorodibenzo-p-dioxin, Bull. Environ. Contam. Toxicol. 21, 463, 1979.
  • Kociba, R. J., Keeler, P. A., Park, C. N., and Gehring, P. J., 2,3,7,8–Tetra- chlorodibenzo-p-dioxin results of a 13– week oral toxicity study in rats, Toxicol. Appl. Pharmacol., 35, 553, 1976.
  • Bowman, R. E., Schantz,S. L., Weerasinghe, N. C. A., Gross, M. L., and Barsotti, D. A., Chronic dietary intake of 2,3,7,8-tetrachlorodibenzo-p-di- oxin (TCDD) at 5 or 25 parts per trillion in the monkey: TCDD kinetics and dose-ef- fect estimate of reproductive toxicity, Chemosphere, 18, 243, 1989.
  • Holloway, M., An epidemic ignored: En- dometriosis linked to dioxin and immuno- logic dysfunction, Scientific American, 4, 24, 1994.
  • United States Environmental Protection Agency (EPA), Special report on environ- mental endocrine disruption: An effects assessment and analysis, EPA/630/R-96/ 012, 1997.
  • Gerhard, I. and Runnebaum, B., Fertil- ity disorders may result from heavy metal and pesticide contamination which limits effectiveness of hormone therapy, Zen- tralblatt Fur Gynakalogie, 114, 593, 1992.
  • Carlsen, E., Giwercman, A., Keiding, N., and Skakkebaek, N. E., Evidence for de- creasing quality of semen during last 50 years, Brit. Med. J., 305, 609, 1992.
  • Sharpe, R. M., Declining sperm counts in men: Is there an endocrine cause?, J. Endocrinol., 136, 357, 1993.
  • Sharpe, R. M. and Skakkebaek, N. E., Are oestrogens involved in falling sperm counts and disorders of the male reproduc- tive tract?, Lancet, 341, 1392, 1993.
  • Ginsburg, K. A. and Armat, D. R., The influence of chamber characteristics on the reliability of sperm concentration and movement measurements obtained bymanual and viseomicrographic analysis, Fertil. Steril., 53, 882, 1990.
  • Seaman, E., Bar-Chama, N., and Fisch, H., Semen analysis in the clinical evalua- tion of infertility, Mediguide to Urology, 7, 1, 1994.
  • Johnson, L., Spermatogenesis and aging in humans, J. Androl., 7, 331, 1986.
  • Levine, R. J., Mathew, R. M., and Bran- don, C., Differences in the quality of se- men in outdoor workers during summer and winter, New Engl. J. Med., 323, 12, 1990.
  • Whorton, M. D. and Meyer, C. R., Sperm count results from 861 American chemi- cal/agricultural workers from 14 separate studies, Fertil. Steril., 42, 82, 1984.
  • Lerda, D., Study of sperm characteristics in persons occupationally exposed to lead, Am. J. Ind. Med., 22, 567, 1992.
  • Wittmaack, F. M. and Shapiro, S. S., Longitudinal study of semen quality in Wisconsin men over one decade, Wiscon- sin Med. J., 91, 477, 1992.
  • MacLeod, J. and Wang, Y., Male fertility potential in terms of semen quality: a re- view of the last, a study of the present, Fert. Steril., 31, 103, 1979.
  • Ratcliffe, J. M. and Gladen, B. C., Does early exposure to maternal smoking affect future fertility in adult males?, Reprod. Toxicol., 6, 297, 1992.
  • Paulsen, C. A., Berman, N. G., and Wang, C., Data from men in greater Seattle area reveals no downward trend in semen qual- ity: Further evidence that deterioration of semen quality is not geographically uni- form, Fertil. Steril., 65, 1015, 1996.
  • Fisch, H., Feldshuh, J., Goluboff, E. T., Broder, S. J., Olson, J. H., and Barad,D. H., Semen analysis in 1,283 men from the United States over a 25–year period: No decline in semen quality, Fertil. Steril., 65, 1009, 1996.
  • Smith, K. D. and Steinberger, E., What is digosperma? cited in: Troen, P. and Nankin, H. R., Eds., The testis in normal and infertile men, Raven Press, New York, 1977, 489.
  • Fisch, H. and Goluboff, E. T., Geographic variations in sperm counts: A potential cause of bias in studies of semen, Fertil. Steril., 65, 1044, 1996.
  • Auger, J., Kunstmann, J. M., Czyglik, F., and Jouannet, P., Decline in semen quality among fertile men in Paris during the last 20 years, New Engl. J. Med., 332, 281, 1995.
  • Sherins, R. J., Are semen quality and male fertility changing? New Engl. J. Med., 332, 327, 1995.
  • Menkveld, R., Van Zyl, J. A., Kotze,T. J. W., and Joubert, G., Possible changes in male fertility over a 15 year period, Arch. Androl., 27, 143, 1986.
  • Bostofte, E., Serup, J., and Rebbe, H., Has the fertility of Danish men declined during the years in terms of semen quality? A comparison of semen quality between 1952 and 1972. Int. J. Fertil., 28, 92, 1972.
  • Osser, S., Liedholm, P., and Ranstram, J., Depressed semen quality: A survey af- ter two decades, Arch. Androl., 12, 113, 1984.
  • Leto, S. and Frensilli, F. J., Changing pa- rameters of donor semen, Fertil. Steril., 36, 766, 1981.
  • Bendvold, E., Semen quality in Norwe- gian men over a 20 year period, Int. J. Fertil., 34, 401, 1989.
  • James, W. H., Secular trend in reported sperm counts, Andrologia, 12, 381, 1980.
  • Brake, A. and Krause, W., Decreasing quality of semen, Brit. Med. J., 305, 1495, 1992.
  • Bromwich, P., Cohen, J., Stewart, I., and Walker, A., Decline in sperm counts: An artefact of changed reference range of “nor- mal”?, Brit. Med. J., 309, 19, 1994.
  • Olsen, G. W., Bodner, K. M., Ramlow,J. M., Ross, C. E., and Lipshultz, L. I., Have sperm counts been reduced 50 per- cent in 50 years? A statistical model revis- ited, Fertil. Steril., 63, 887, 1995.
  • Mably, T. A., Bjerke, D. L., Moore,R. W., Gendron-Fitzpatrick, A., and Peterson, R. E., In utero and lactational exposure of male rats to 2,3,7,8-tetrachloro-p-dioxin. III. Effects on spermatogenesis and reproductive capacity, Tox. Appl. Pharmcol., 114, 118, 1992.
  • Bjerke, D. L. and Peterson, R. E., Repro- ductive toxicity of 2,3,7,8-tetrachloro- dibenzo-p-dioxin in male rats: Different effects of in utero vs. lactational exposure, Toxicol. Applied Pharmacol., 127, 241, 1994.
  • Wilker, C., Johnson, L., and Safe, S., Effects of developmental exposures to in- dole-3–carbinol or 2,3,7,8-tetrachloro-p- dioxin on reproductive potential of male rat offspring, Fund. Appl. Toxicol., 141, 68, 1996.
  • Wolfe, W. H., Michalek, J. E., Miner,J. C., and Rahe, A. J., An epidemiologic investigation of health effects in air force personnel following exposure to herbicides: Extract, reproductive outcomes, executive summary, introduction and conclusions, in Air Force Health Study, Epidemiology Research Division, Armstrong Laboratory, Brooks Air Force Base, TX, 1992.
  • Emmett, E. A., Maroni, M., Jefferys, J., Schmith, J., Levin, B. K., and Alvares, A., Studies of transformer repair workers exposed to PCBs. II. Results of clinical laboratory investigations, Am. J. Ind. Med., 14, 47, 1988.
  • Dalterio, S., Badr, F., Bartke, A., and Mayfield, D., Cannabinoids in male mice: Effects on fertility and spermatogenesis, Science, 216, 315, 1982.
  • Dalterio, S. and Bartke, A., Perinatal ex- posure to cannabinoids alters male repro- ductive function in mice, Science, 205, 1420, 1979.
  • Ahluwalia, B. S., Rajguru, S. U., and Nolan, G. H., The effect of 9–tetrahydro- cannabinol in utero exposure on rat off- spring fertility and ventral prostate gland morphology, J. Androl., 6, 386, 1985.
  • Osser, S., Beckman-Ramirez, A., and Liedholm, P., Semen quality or smoking and non-smoking men in infertile couples in a Swedish population, Acta. Obstet. Gynecol. Scand., 71, 215, 1992.
  • John Radcliffe Hospital Cryptorchidism Study Group, Cryptorchidism: An appar-ent substantial increase since 1960, Br. Med. J., 293, 1401, 1986.
  • John Ratcliffe Hospital Cryptorchidism Study Group, Cryptorchidism: A prospec- tive study of 7,500 consecutive male births, 1985–8, Arch. Dis. Childhood, 67, 892, 1992.
  • Scorer, C. G., The incidence of incom- plete descent of the testicle at birth, Arch. Dis. Child., 31, 198, 1956.
  • Berkowitz, G. S., Lapinski, R. H., Dolgin,S. E., Gazella, J. G., Bodian, C. A., and Holzman, I. R., Prevalence and natural history of cryptorchidism, Pediatrics, 92, 44, 1993.
  • Frey, H. L. and Rajfer, J., Incidence of cryptorchidism, Urol. Clin. North Am., 9, 327, 1982.
  • Berkowitz, G. S., Lapinski, R. H., Godbold, J. H., and Dolgin, S. E., Mater- nal and neonatal risk factors for cryptorchid- ism, Epidemiology, 6, 127, 1995.
  • Anon., An increasing incidence of cryp- torchidism and hypospadias? Lancet, I, 1311, 1985.
  • Rozanski, T. A. and Bloom, D. A., The undescended testis: Theory and manage- ment, Urol. Clin. North Am., 22, 107, 1995.
  • Beard, M., Melton, L. J., O’Fallon, W. M., Noller, K. L., and Benson, R. C., Cryptorchism and maternal estrogen expo- sure, Amer. J. Epidemiol. ,120, 707, 1984.
  • Andonian, R. W. and Kessler, R., Trans- placental exposure to diethylstilbestrol in men, Urology, 8, 276, 1979.
  • Cosgrove, M. D., Benton, B., and Henderson, B. E., Male genitourinary ab- normalities and maternal diethylstilbestrol, J. Urol., 177, 220, 1977.
  • Guo, Y. L., Lai, T. J., Ju, S. H., Chen, Y. C., and Hsu, C. C., Sexual developments and biological findings in Yucheng chil- dren, cited in: Dioxin ’93: 13th Interna- tional Symposium on Chlorinated Dioxins and Related Compounds, 14, 235, 1993.
  • Guillette, Jr. L. J., Gross, T. S., Masson,G. R., Matter, J. M., Percival, H. F., and Woodward, A. R., Developmental abnor- malities of the gonad and abnormal sex hormone concentrations in juvenile alliga- tors from contaminated and control lakes in Florida, Environ. Health Perspect., 102, 680, 1994.
  • Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., and Wilson, E. M., Persistent DDT metabolite p,p-DDE is a potent androgen receptor antagonist, Nature, 375, 581, 1995.
  • Masuda, Y., Kuroki, H., Yamaryo, T., Haraguchi, K., Karatsune, M., and Hsu, S.T., Comparison of causal agents in Tai- wan and Fukuoka PCB poisonings, Chemo- sphere, 11, 199, 1982.
  • Chen, P. H., Chang, K. T., and Lu, Y. D., Polychlorinated biphenyls and polychlori- nated dibenzofurans in the toxic rice-bran oil caused by PCB poisoning in Taichung, Bull. Environ. Contam. Toxicol, 26, 489, 1981.
  • Yoshimura, T. and Hayabuchi, H., Rela- tionship between the amount of rice oil ingested by patients with Yusho and their subjective symptoms, Environ. Health Perspect., 59, 47, 1985.
  • Kuratsune, M., Yusho, with reference to Yu-Cheng, in Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products, 2nd edition, Kim- brough, R. D. and Jensen, A. A., Eds., Elsevier Press, New York, 381,1989.
  • Kuratsune, M., Masuda, Y., and Nagay- ama, J., Some of the recent findings con- cerning Yusho, Proceedings of the National Conference on Polychlorinated Biphenyls, 14, 1976.
  • Masuda, Y., Health status of Japanese and Taiwanese after exposure to contaminated rice oil, Environ. Health Perspect., 60, 321, 1985.
  • Ryan, J. J., Schecter, A., Masuda, Y., and Kikuchi, M., Comparison of PCDDs and PCDFs in the tissues of Yusho patients with those from the general population in Japan and China, Chemosphere, 16, 2017, 1987.
  • Ryan, J. J., Gasiewicz, T. A., and Brown,J. F., Jr. Human body burden of polychlo- rinated dibenzofurans associated with tox- icity based on the Yusho and Yu-Cheng incidents, Fund. Appl. Toxicol., 15, 722,1990.
  • Guo, Y. L., Lin, C. J., and Yao, W. J., Musculoskeletal changes in children pre- natally exposed to polychlorinated biphe- nyls and related compounds (Yu-Cheng children), J. Toxicol. Environ. Health, 41, 83, 1994a.
  • Guo, Y. L., Chen, Y. C., Yu, M. L., and Hsu, C. C., Early development of Yu- Cheng children born seven to twelve years after the Taiwan PCB outbreak, Chemo- sphere, 29, 2395, 1994b.
  • Masuda, Y., Approach to risk assessment of chlorinated dioxins from Yusho PCB poisoning, Organohalogen Compounds, 21, 1, 1994.
  • Bruckner, J. V., Letter, to Agency for Toxic Substances and Disease Registry, Division of Toxicology, Atlanta, GA, May 4, 1993.
  • Guyton, A. C., Textbook of Medical Physi- ology, 2nd ed., W. B. Saunders, Philadel- phia, PA, 1180, 1961.
  • Gray Jr., L. E., Ostby, J. S., and Kelce,W. R., Developmental effects of an envi- ronmental antiandrogen: The fungicide vinclozolin alters sex differentiation of the male rat, Toxicol. Appl. Pharmacol., 129, 46, 1994.
  • Wagner, M. G. and Stephenson, P. A., Infertility in industrialized countries: Preva- lence and prevention, Soz Praventivmed, 37, 213, 1992.
  • World Health Organization (WHO), Steep decline in world fertility rates: Con- traceptive use up sharply, Soz Praven- tivmed, 37, 254, 1992.
  • Leke, R. J., Oduma, J. A., Bassol- Mayagoitia, S., Bacha, A. M., and Grigor,K. M., Regional and geographical varia- tions in infertility: Effects of environmen- tal, cultural, and socioeconomic factors, Environ. Health Perspect., 101, Suppl. 2, 73, 1993.
  • Olsen, J., Is human fecundity declining — and does occupational exposures play a role in such a decline if it exists?, Scand. J. Work Environ. Health, 20, 72, 1994.
  • Swerdloff, R. S., Infertility in the male, Ann. Intern. Med., 103, 906, 1985.
  • Lundsberg, L. S., Bracken, M. B., and Belanger, K., Occupationally related mag- netic field exposure and male subfertility, Fert. Steril., 63, 384, 1995.
  • Westrom, L. V., Environmentally persis- tent alkylphenolic compounds are estro- genic, Sex Transm. Dis. Suppl. 21, S32, 1994.
  • Thonneau, P., Ducot, B., and Spira, A., Risk factors in men and women consulting for infertility, Int. J. Fertil. Menopausal Stud., 38, 37, 1993.
  • Steeno, O. P. and Pangkahila, A., Occu- pational influences on male infertility and sexuality, Andrologia, 16, 22, 1984.
  • Schrag, S. D. and Dixon, R. L., Occupa- tional exposures associated with male re- productive dysfunction, Ann. Rev. Pharma- col. Toxicol. 25, 567, 1985.
  • Witkin, S. S., Jeremias, J., Grifo, J. A., and Ledger, W. J., Detection of chlamy- dia trachomatis in semen by the polymerase chain reaction in male members of infertile couples, Am. J. Obstet. Gynecol., 168, 1457, 1993.
  • Wolff, H., Neubert, U. and Zebhauser, M., Bezold, G., Korting, H. C., and Meurer, M., Chlamydia trachomatic in- duces an inflammatory response in the male genital tract and is associated with altered semem quality, Fertil. Steril., 55, 1017, 1991.
  • Micic, S., Petrovic, S., and Dotlic, R., Seminal antisperm antibodies and genitouri- nary infection, Urology, 8, 54, 1990.
  • Bracken, M. B., Eskenazi, B., Sachse, K., McSharry, J. E., Hellenbrand, K., and Summers, L. L., Association of co- caine use and sperm concentration, motil- ity and morphology, Fertil. Steril., 53, 315, 1990.
  • Stenchever, M. A., Williamson, R. A., Leonard, J., Karp, L. E., Ley, B., Shy, K., and Smith,D., Possible relationship between in utero diethylstilbestrol expo- sure and male fertility, Am. J. Obstet. Gynecol., 140, 186, 1981.
  • Shy, K. K., Stenchever, M. A., Karp, L. E., Berger, R. E., Williamson, R. A., and Leonard, J., Genital tract examinations and zona-free hamster egg penetration tests from men exposed in utero to diethylstil- bestrol, Fertil. Steril., 42, 772, 1984.
  • Pines, A., Cucos, S., Ever-Hardani, P., and Ron, M., Some organochlorine insec- ticide and polychlorinated biphenyl blood residues in infertile males in the general Israeli population of the middle 1980s, Arch. Environ. Contam. Toxicol., 16, 587, 1987.
  • Kaufman, R. H. and Binder, G. L., Up- per genital tract changes associated with exposure in utero to diethylstilbestrol, Am.J. Obstet. Gynecol., 128, 51, 1977.
  • Kaufman, R. H., Noller, K., Adam, E., Irwin, J., Gray, M., Jefferies, J. A., and Hilton, J., Upper genital tract abnormali- ties and pregnancy outcome in diethylstil- bestrol-exposed progeny, Obstet. Gynecol., 148, 973, 1984.
  • Kaufman, R. H., Adam, E., Noller, K., Irwin, J. F., and Gray, M., Upper genital tract changes and infertility in diethylstil- bestrol-exposed women, Am. J. Obstet. Gynecol, 154, 1312, 1986.
  • Barnes, A. B., Menstrual history of young women exposed in utero to diethylstil- bestrol, Fertil. Steril., 32, 148, 1979.
  • Barnes, A., Colton, T., and Gunderson, J., Fertility and outcome of pregnancy in women exposed in utero to diethylstil- bestrol, N. Engl. J. Med., 302, 609, 1980.
  • Barnes, A. B., Menstrual history and fe- cundity of women exposed and unexposed in utero to DES, J. Reprod. Med., 29, 651, 1984.
  • Herbst, A. L. and Bern, H. A., Eds., De- velopmental Effects of Diethylstilbestrol in Pregnancy, Thieme-Stratton, New York, 1982.
  • Cousins, L., Karp, W., Lacey, C., and Lucas, W. E., Reproductive outcome of women exposed to diethylstilbestrol in utero, Obstet. Gynecol., 56, 70, 1980.
  • Senekjian, E. K., Potkul, R. K., Frey, K., and Herbst, A. L., Infertility among daugh- ters either exposed or not exposed to dieth-ylstilbestrol, Am. J. Obstet. Gynecol., 158, 493, 1988.
  • Berger, M. J. and Goldstein, D. P., Im- paired reproductive performance in DES- exposed women, Obstet. Gynecol., 55, 25, 1980.
  • Jefferies, J. A., Robboy, S. J., O’Brien,P. C., Bergstralh, E. J., Labarthe, D. R., Barnes, A. B., Noller, K. L., Hatab, P. A., Kaufman, R. H., and Townsend, D. E., Structural anomalies of the cervix and va- gina in women enrolled in the Diethylstil- bestrol Adenosis (DESAD) project, Am. J. Obstet. Gynecol., 148, 59,1984.
  • Schmidt, G., Fowler, W. C., Talbert,L. M., and Edelman, D. A., Reproductive history of women exposed to diethylstil- bestrol in utero, Fertil. Steril., 33, 21, 1980.
  • Ben-Baruch, G., Menczer, J., Mashiach, S., and Serr, D. M., Uterine anomalies in diethylstilbestrol-exposed women with fer- tility problems, Acta Obstet. Gynecol. Scand., 60, 395, 1981.
  • Goldstein, D. P., Incompetent cervix in off- spring exposed to diethylstilbestrol in utero, Obstet. Gynecol., 52, 735, 1978.
  • O’Brien, P. C., Noller, K. L., and Robboy, S. J., Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project, Obstet. Gynecol., 53, 300, 1979.
  • Bibbo, M., Haenszel, W. M., and Wied,G. L., A twenty-five year follow-up study of women exposed to diethystilbestrol dur- ing pregnancy, N. Engl. J. Med., 298, 763, 1978.
  • Veridiano, N. P., Delke, I., Rogers, J., and Tancer, M. L., Reproductive perfor- mance of DES-exposed female progeny, Obstet. Gynecol., 58, 58, 1981.
  • Leoni, V., Fabiani, L., Marinelli, G., and Puccetti, G., PCB and other organochlo- rine compounds in blood in women with or without miscarriage: A hypothesis of cor- relation, Ecotoxicol. Environ. Safety, 17, 1, 1989.
  • Kimbrough, R. D., Polychlorinated biphe- nyls (PCBs) and human health: An update, Crit. Review. Toxicol., 25, 133, 1995.
  • Byne, W. and Parsons, B., Human sexual orientation: The biologic theories reap- praised, Arch. Gen. Psychiatry, 50, 228, 1993.
  • Kester, P., Green, R., Finch, S. J., and Williams, K., Prenatal female hormone administration and psychosexual develop- ment in human males. Psychoneuro- endocrinology, 5, 269, 1980.
  • Reinisch, J. M., Ziemba-Davis, M., and Sanders, S. A., Hormonal contributions to sexually dimorphic behavioral development in humans, Psychoneuroendocrinology, 16, 213, 1991.
  • Meyer-Bahburg, H. F., Ehrhardt, A. A., Rosen, L. R., Gruen, R. S., Veridiano,N. P., Vann, F. H., and Neuwalder, H. F., Prenatal estrogens and the development of homosexual orientation, Develop. Psych., 31, 12, 1995.
  • Hines, M., Prenatal gonadal hormones and sex differences in human behavior, Psychol. Bull., 92, 56, 1982.
  • Grisham, W., Kerchner, M., and Ward,I. L., Prenatal stress alters sexually dimor- phic nuclei in the spinal cord of male rats, Brain Res., 551, 126, 1991.
  • Velazquez-Moctezuma, J., Dominguez Salazar, E.,and Cruz Rueda, M. L., The effect of prenatal stress on adult sexual behavior in rats depends on the nature of the stressor, Physiol. Behav., 53, 443, 1993.
  • Hermans, R. H., McGivern, R. F., Chen, W., and Longo, L. D., Altered adult sexual behavior in the male rat following chronic prenatal hypoxia, Neurotoxicol. Teratol., 15, 353, 1993.
  • Ward, I. L. and Weisz, J., Maternal stress alters plasma testosterone in fetal males, Science, 207, 328, 1980.
  • Ward, I. L. and Stehm, K. E., Prenatal stress feminizes juvenile play patterns in male rats, Physiol. Behav., 50, 601, 1991.
  • Lichtensteiger, W. and Schlumpf, M., Prenatal nicotine affects fetal testosterone and sexual dimorphism of saccharin pref- erence, Pharmacol. Biochem. Behav., 23, 439, 1985.
  • McGivern, R. F., Clancy, A. N., Hill,M. A., and Noble, E. P., Prenatal alcohol exposure alters adult expression of sexu- ally dimorphic behavior in the rat, Science, 224, 896, 1984.
  • Parker, S., Udani, M., Gavaler, J. S., and Van Thiel, D. H., Adverse effects of ethanol after the adult sexual behavior of male rats exposed in utero, Neurobehav. Toxicol. Teratol., 6, 289, 1984.
  • Raum, W. J. McGivern, R. F., Peterson, M. S. Shryne, J. H., and Forski, R. A., Prenatal inhibition of hypothalamic sex steroid uptake by cocaine: Effects on neurobehavioral sexual differentiation in male rats, Develop. Brain Res., 53, 230, 1990.
  • Udani, M., Parker, S., Favaler, J., and van Thiel, D. H., Effects of in utero expo- sure to alcohol after male rats, Alcohol. Clin. Exp. Res., 9, 355, 1985.
  • Pizzi, W. J., Barnhart, J. E., and Fanslow,D. J., Monosodium glutamate administra- tion to the newborn reduces reproductive ability in female and male mice, Science, 196, 452, 1977.
  • Hsu, C. C., Hu, H. F., Lai, T. J., Ko, H. C., and Chen, Y. C., Behavioral develop- ment of Yucheng children as compared with their matched controls, in Dioxin ’93: 13th International Symposium on Chlori- nated Dioxins and Related Compounds, 14, 239, 1993.
  • Hovinga, M. E., Sowers, M., and Humphrey, H. E. B., Histological changes in serum PCB and DDT levels in an envi- ronmentally exposed cohort, Arch. Environ. Contam. Toxicol., 22, 362, 1992.
  • Massuchusetts Department of Public Health, Final report of Greater New Bedford PCB Health Effects Study 1984– 1987, Boston, MA, 1987.
  • Humphrey, H. E. B., Population studies of PCBs in Michigan residents, in Human and Environmental Hazards, D’Itri, F. M. and Kamrin, M., Eds., Butterworth, Bos- ton, 1983, 299.
  • Cole, D. C., Kearney, J., Gilman, A. P., and Ryan., J. J., Serum PCB, dioxin and furan levels in Ontario Great Lakes An- glers, Organohalogen Compounds, 26, 193, 1995.
  • Kreiss, K., Studies of population exposed to polychlorinated biphenyls, Environ. Health Perspect., 60, 193, 1985.
  • Chen, Y. C., Guo, Y. L., Hsu, C. C., and Rogan, W. J., Cognitive development of Yu-Cheng children prenatally exposed to heat-degraded PCBs, J. Amer. Med. Assoc., 268, 3213, 1992.
  • Truscott, S. D., Narrett, C. M., and Smith, S. E., WISC-R subtest reliability over time: Implications for practice and research, Psychol. Rep., 74, 147, 1994.
  • Lai, T. J., Guo, Y. L., Yu, M. L., and Ko,H. C., Cognitive development in Yu Cheng children, Chemosphere, 29, 2405, 1994.
  • Guo, Y. L., Lai, T. J., Chen, S. J., and Hsu, C. C., Gender-related decrease in raven’s progressive matrices scores in chil- dren prenatally exposed to polychlorinated biphenyls and related compounds, Bull. Environ. Contam. Toxicol., 55, 8, 1995.
  • Guo, Y. L., Yu, M. M., and Ryan, J. J., Different congeners of PCBs/PCDFs may have contributed to different health out- comes in the Yucheng cohort, Neurotox. Teratol., 18, 255, 1996.
  • Yu, M. L., Hsu, C. C., and Guo, Y. L., Disordered behavior in the early-born Tai- wan Yu-Cheng children, Chemosphere, 29, 2413, 1994.
  • Tanabe, S., Kannan, N., Wakimoto, T., Tatsukawa, R., and Okamoto, T., Isomer specific determination and toxic evalua- tion of potentially hazardous coplanar PCBs, dibenzofurans, and dioxins in the tissues of “Yusho” PCB poisoning victim and in the causal oil, Toxicol. Environ. Chem., 24, 215, 1989.
  • Fein, G. G., Jacobson, J. L., Jacobson, S. W., Schwartz, P. M., and Dowler, J. K., Prenatal exposure to polychlorinated bi- phenyls: Effects on birth size and gesta- tional age, J. Pediatrics, 105, 315, 1984.
  • Jacobson, J. L., Fein, G. G., Schwartz,P. M., and Dowler, J. K., Prenatal exposure to an environmental toxin: A test of the multiple effects model, Develop. Psychol., 20, 523, 1984.
  • Jacobson, S. W., Fein, G. G., Jacobson,J. L., Schwartz, P. M., and Dowler, J. K.,The effects of intrauterine PCB exposure on visual recognition memory, Child Dev., 56, 853, 1985.
  • Jacobson, J. L., Jacobson, S. W., and Humphrey, H. E. B., Effects of exposure to PCBs and related compounds on growth and activity in children, Neurotox. Teratol., 12, 319, 1990a.
  • Jacobson, J. L., Jacobson, S. W., and Humphrey, H. E. B., Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive function- ing in young children, J. Pediatrics, 116, 38, 1990b.
  • Schwartz, P. M., Jacobson, S. W., Fein, G., Jacobson, J. L., and Price, H. A., Lake Michigan fish consumption as a source of polychlorinated biphenyls in human cord serum, maternal serum, and milk, Amer. J. Pub. Health, 73, 293, 1983.
  • Paneth, N., Human reproduction after in- gestion of PCB-contaminated fish, Health Environ. Digest, 5, 4, 1991.
  • Swain, W. R., Effect of organochlorine chemicals on the reproductive outcome of humans who consumed contaminated Great Lakes fish: An epidemiologic consideration, J. Toxicol. Environ. Health, 33, 587, 1991.
  • Agency for Toxic Substances and Dis- ease Registry (ATSDR), Toxicological Profile for Mercury, United States Depart- ment of Health and Human Services, Wash- ington, D. C., 1993b.
  • Dar, E., Kanarek, M. S., Anderson, H. A., and Sonzogni, W. C., Fish consump- tion and reproductive outcomes in Green Bay, Wisconsin, Environ. Res., 59, 189, 1992.
  • Rogan, W. J., Gladen, B. C., and McKinney, J. D., Polychlorinated biphe- nyls (PCBs) and dichlorodiphenyl dichloro- ethane (DDE) in human milk: Effects of maternal factors and previous lactation, Am. J. Health, 76, 172, 1986a.
  • Rogan, W. J., Gladen, B. C., Mckinney,J. D., Carreras, N., Hardy, P., Thullen, J., Tinglestad, J., and Tully, M., Neona- tal effects of transplacental exposure to PCBs and DDE, J. Pediatr., 8, 335, 1986b.
  • Gladen, B. C., Rogan, W. J., Hardy, P., Thullen, J., Tinglestad, J., and Tully, M., Development after exposure to polychlori- nated biphenyls and dichlorophenyl dichloroethene transplacentally and through human milk, J. Pediatr., 113, 991, 1988.
  • Gladen, B. C. and Rogan, W. J., Effects of perinatal polychlorinated biphenyls and dichlorodiphenyl dichloroethane on later development, J. Pediatr., 119, 58, 1991.
  • Brazelton, T. B., Nugent, J. K., and Lester, B. M., Neonatal Behavioral As- sessment Scale, Lippincott, Philadelphia, 780, 1973.
  • Lonky et Lonkey, E., Reihman, J., Darvill, T., Mather, J., and Daly, H., Neonatal behavioral assessment scale per- formance in humans influenced by mater- nal consumption of environmentally con- taminated Lake Ontario fish, J. Great Lakes Res., 22, 198, 1995.
  • Safe, S. H., Polychlorinated biphenyls (PCBs): Environmental impact, biochemi- cal and toxic responses, and implications for risk assessment, Crit. Rev. Toxicol., 24, 87, 1994.
  • Schantz, S. L., Developmental neurotox- icity of PCBs in humans: What do we know and where do we go from here?, Neurotox. Teratol., 18, 217, 1996.
  • Koopman-Esseboom, C., Morse, D. C., Weisglas-Kuperus, N., Lutkeschipholt,I. J., van der Paauw, C. G., Tuinstra, L.G. M. T., Brouwer, A., and Sauer, P. J. J., Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants, Pediat- ric Research, 36, 468, 1994.
  • Bowman, R. E., Hieonimus, M. P., and Allen, J. R., Correlation of PCB body bur- den with behavioral toxicology in mon- keys, Pharmacol. Biochem. Behav., 9, 49, 1978.
  • Mele, P. C., Bowman, R. E., and Levin,E. D., Behavioral evaluation of perinatal PCB exposure in rhesus monkeys: fixed- interval performance and reinforcement- omission, Neurobehav. Tox. Teratol., 8, 131, 1986.
  • Levin, E. D., Schantz, S. L., and Bow- man, R. E., Delayed spatial alternation deficits resulting from perinatal PCB ex- posure in monkeys, Arch. Toxicol., 62, 267, 1988.
  • Schantz, S. L. and Bowman, R. E., Learn- ing in monkeys exposed perinatally to 2,3,7,8– tetrachlorodibenzo-p-dioxin (TCDD), Neurotox. Teratol., 11, 13, 1989.
  • Bowman, R. E., Schantz, S. L., Ferguson,S. A., Tong, H. Y., and Gross, M. L., Controlled exposure of female Rhesus monkeys to 2,3,7,8–TCDD: Cognitive be- havioral effects in their offspring, Chemo- sphere 20, 1103, 1990.
  • Swerdlow, A. J., The epidemiology of tes- ticular cancer, Eur. Urol. Suppl. 23, 35, 1993.
  • Osterlind, A., Diverging trends in inci- dence and mortality of testicular cancer in Denmark, Brit. J. Cancer, 53, 501, 1986.
  • Moller, H., Clues to the aetiology of tes- ticular germ cell tumours from descriptive epidemiology, Eur. Urol., 23, 8, 1993.
  • Bergstrom, R., Adami, H.-O., Möhner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Akre, O., and Hakulinen, T., Increase in testicular can- cer incidence in six European countries: A birth cohort phenomenon, J. Natl. Cancer Inst., 88, 727, 1996.
  • Boyle, P. and Zaridze, D. G., Proceed- ings: Risk factors for prostate and testicu- lar cancer, Eur. J. Cancer, 29A, 1048, 1993.
  • Ross, R. K., Mccurtis, J. W., Henderson,B. E., Menck, H. R., Mack, T. M., and Martin, S. P., Descriptive epidemiology of testicular and prostatic cancer in Los Angeles, Br. J. Cancer, 39, 284, 1979.
  • Fram, R. J., Garnick, M. B., and Retik, A., The spectrum of genitourinary abnor- malities in patients with cryptorchidism, with emphasis on testicular carcinoma, Cancer, 50, 2243, 1982.
  • Henderson, B. E., Benton, B., Jing, J., Yu, M. C., and Pike, M. C., Risk factors for cancer of the testis in young men, Int. J. Cancer, 23, 598, 1979.
  • Morrison, A. S., Cryptorchidism, hernia, and cancer of the testis, J. Natl. Cancer Inst., 56, 731, 33, 1976.
  • Kuber, W., Testicular tumor and cryp- torchidism, Eur. Urol., 8, 280, 1982.
  • Moss, A. R., Osmond, D., Bacchetti, P., Torti, F. M., and Gurgin, V., Hormonal risk factors in testicular cancer, Amer. J. Epid., 124, 39, 1986.
  • Depue, R. H., Pike, M. C., and Hender- son, B. E., Estrogen exposure during ges- tation and risk of testicular cancer, J. Natl. Can. Inst., 71, 1151, 1983.
  • DeLeval, J. and Vandeberg, C., Testis tumor: The problem of the undescended testis, JBR-BTR, 76, 100, 1993.
  • United Kingdom Testicular Cancer Study Group (UKTCSG), Aetiology of testicular cancer: Association with congeni- tal abnormalities, age at puberty, infertil- ity, and exercise, Brit. Med. J., 308, 1393, 1994.
  • Thune, I. and Lund, E., Physical activity and the risk of prostate and testicular can- cer: a cohort study of 53,000 Norwegian men, Cancer Causes Con., 5, 549, 1994.
  • Verreault, R., Weiss, N. S., Hollenbach,K. A., Strader, C. H., and Daling, J. R., Use of electric blankets and risk of testicu- lar cancer, Am. J. Epidemiol., 131, 759, 1990.
  • Bullock, B. C., Newbold, R. R., and McLachlan, J. A., Lesions of testis ad epididymis associated with prenatal dieth- ylstilbestrol exposure, Environ. Health Perspect., 77, 29, 1988.
  • Gershman, S. T. and Stolley, P. D., A case-control study of testicular cancer us- ing Connecticut tumour registry data, Int. J. Epidemiol., 17, 738, 1988.
  • Conley, G. R., Sant, G. R., and Ucci,A. A., Seminoma and epidymal cysts in a young man with known diethylstilbestrol exposure in utero, J. Amer. Med. Assoc., 249:1325–6. 1983
  • Rajpert-De Meyts, E., and Skakkeboek,N. E., The possible role of sex hormones in the development of ttesticular cancer, Eur. Urol., 23, 54, 1993.
  • Braun, M. M., Ahlbom, A., Floderus, B., Brinton, L. A., and Hoover, R. N., Effect of twinship on incidence of cancer of the testis, breast, and other sites, Cancer Causes and Control, 6, 519, 1995.
  • Pylkkanen, L., Jahnukainen, K., and Santti, R., Testicular toxicity and mutage- nicity of steroidal and non-steroidal estro- gens in the male mouse, Mut. Res., 261, 181, 1991.
  • Potosky, A. L., Miller, B. A., Albertsen,P. C., and Kramer, B. S., The role of increasing detection in the rising incidence of prostate cancer, J. Am. Med. Assoc., 273, 548, 1995.
  • McCaul, K. A., Luke, C. G., and Roder,D. M., Trends in prostate cancer incidence and mortality rates in South Australia, 1977–1993, Med. J. Aust., 162, 520, 1995.
  • DeVito, M. J., Maier, W. E., Delberto, J. J., and Birnbaum, L. S., Comparative abil- ity of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment, Fund. Appl. Toxicol., 20, 125, 1993.
  • Gardner W. A., Jr. and Bennett, B. D., The prostate—Overview: Recent insights and speculations, Mono. Pathol., 34, 129, 1992.
  • Bosland, M. C., Animal models for the study of prostate carcinogenesis, J. Cell. Biochem. Suppl. 16H, 89, 1992a.
  • Bosland, M. C., Dreef-Van Der Muslen,H. C., Sukumar, S., Ofner, P., Leav, I., Han, X., and Liehr, J. G., Multistage pros- tate carcinogenesis: the role of hormones, in Multistage Carcinogenesis,CRC Press, Boca Raton, 1992b, 109.
  • Santti, R., Pylkkanen, L., Newbold, R., and McLachlan, J. A., Editorial: Devel- opmental oestrogenization and prostatic neoplasia, Int. J. Androl., 13, 77, 1990.
  • Santti, R., Newboldmark, R. R., Makela, S., Pylkkanen, L., and Mclachlan, J. A., Developmental estrogenization and pros- tatic neoplasia, Prostate, 24, 67, 1994.
  • National Cancer Institute (NCI), National Cancer Institute roundtable on prostat cancer: future research directions, Chiarodo, A. (Ed), Can. Res., 51, 2498, 1991.
  • Shirai, T., Imaida, K., Masui, T., and Iwasaki, S., Effects of testosterone, dihydrotestosterone and estrogen on 3,2- dimethyl-4-aminobiphenyl-induced rat prostate, Int. J. Cancer, 57, 224, 1994.
  • DeVita, V. T., Hellman, S., and Rosen- berg, S. A., Cancer: Principles and Prac- tice of Oncology, 4th ed., J. B. Lippincott, Philadelphia, PA, 1993.
  • Agency for Toxic Substances and Dis- ease Registry (ATSDR), Toxicological Profile for Chlorinated Dibenzo-p-Diox- ins, United States Department of Health and Human Services, Washington, D. C., 1996.
  • Reijnders, P. J., Toxicokinetics of chlorobiphenyls and associated physiologi- cal responses in marine mammals, with particular reference to their potential for ecotoxicological risk assessment, Sci. To- tal Environ., 154, 229, 1994.
  • Deguise, S., Martineau, D., Beland, P., and Fournier, M., Possible mechanisms of action of environmental contaminants on St. Lawrence beluga whales (Del- phinapterus leucas), Environ. Health Perspect., 103, 73, 1995.
  • Klein, P. A., Immunology and biotechnol- ogy for the study and control of infectious diseases in wildlife populations, J. Zoo Wildlife Med., 24, 346, 1993.
  • Stites, D. P, Terr, A. I., and Parslow,T. G., Eds., Basic and Clinical Immunol- ogy, 8th ed., Appleton and Lange, Norwalk, CT., 1994, 870.
  • Ways, S. C. and Mortola, J. F., Alter- ations in immune responsiveness in women exposed to diethylsilbestrol in utero. Fertil. Steril. 48, 193, 1987.
  • Ford, C. D., Johnson, G. H., and Smith,W. G., Natural killer cells in utero diethyl- stilbestrol-exposed patients, Gynecol. Oncol., 16, 400, 1983.
  • Wingard, D. L. and Turiel, J., Long-term effects of exposure to DES, Western J. Med., 149, 551, 1988.
  • Noller, K. L., Blair, P. B., O’Brien, P. C., Melton III, L. J., Offord, J. R., Kaufman, R. H., and Colton, T., Increased occur- rence of autoimmune disease among women exposed in utero to diethyl- stilbestrol, Fertil. Steril., 49, 1080, 1988.
  • Blair, A., Linos, A., Stewart, P. A., Burmeister, L., Gibson, R., Everett, G., Shumann, L., and Cantor, K. P., Com- ments on Occupational and Environmental Factors in the Origin of Non-Hodgkin’s Lymphoma, Cancer Research, 52, 5501, 1992.
  • Helgason, S. and Schoultz, B. V., Estro- gen replacement therapy and mixed lym- phocyte reaction, Amer. J. Obstet. Gynecol., 141, 393, 1981.
  • Kalland, T., Alterations of antibody re- sponse in female mice after neonatal expo- sure to diethylstilbestrol, J. Immunol, 124, 194, 1980a.
  • Kalland, T., Reduced natural killer activ- ity in female mice after neonatal exposure to diethylstilbestrol, J. Immunol., 124, 1297, 1980b.
  • Kalland, T., Decreased and disproportion- ate T cell population in adult mice after neonatal exposure to diethylstilbestrol, Cell. Immunol., 51, 55, 1980c.
  • Kalland, T. and Forsberg, J-G., Natural killer cell activity and tumor susceptibility in female mice treated neonally with diethystilbestrol, Cancer Res., 41, 5134, 1981.
  • Kalland, T., Long-term effects on the im- mune system of an early life exposure to diethylstilbestrol, In Environmental Fac- tors in Human Growth and Development, Banbury Report 11., Hunt, V. R., Smith,M. K., and Worth, D., Eds., Cold Spring Harbor Laboratory, 217, 1991.
  • Kalland, T., Fossberg, T. M., and Forsberg, J.G., Effect of estrogen and corticosterone on the lymphoid system in neonatal mice, Exper. Mol. Path., 28, 76, 1978.
  • Luster, M., Faith, R., McLachlan, J., and Clark, G., Effect of in utero exposure to diethylstilbestrol on the immune response in mice, Toxicol. Appl. Pharmacol., 47, 279, 1979.
  • Blair, P. B., Immunological consequences of early exposure of mice to diethylstil- bestrol, cited in: Clinical Practice of Gyne- cology, 2nd ed. Elsevier, New York, 1990, 91.
  • Ways, S. C., Blair, P. B., Bern, H. A., and Staskawicz, M. O., Immune respon- siveness of adult mice exposed neonatally to diethylstilbestrol, steroid hormones, or vitamin A, J. Env. Path. Toxicol., 3, 207, 1980.
  • Kalland, T., Strand, O., and Forsberg, J. G., Longterm effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes, J. Natl. Can- cer Inst., 63, 413, 1979.
  • Blair, P. B., Immunological consequences of early exposure of experimental rodents to diethylstilbestrol and steroid hormones, cited in: Bern, H. A. and Herbst, A. L., Eds., Developmental Effects of Diethylstil- bestrol (DES) in pregnancy, Thieme- Statton, New York, 1981, 167.
  • Tryphonas, H., Immunotoxicity of poly- chlorinated biphenyls: Present status and future considerations, Exp. Clin. Immuno- genet., 11, 149, 1994.
  • Agency for Toxic Substances and Dis- ease Registry (ATSDR), Toxicological Profile for Polychlorinated Biphenyls, United States Department of Health and Human Services, Washington, D. C., 1995.
  • International Programme on Chemical Safety (IPSC), Persistent organic pollut- ants: An assessment report on DDT- aldrin-dieldrin-endrin-chlordane-hep- tachlor-hexachlorobenzene-mirex-toxa- phene-polychlorinated biphenyls-dioxins and furans, Inter-Organizational Pro- gramme for the Sound Management of Chemicals, 1995.
  • Smialowicz, R. J., Riddle, M. M., Will- iams, W. C., and Diliberto, J. J., Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lym- phocyte subpopulations: Differences be- tween mice and rats, Toxicol. Appl. Pharmacol., 124, 248, 1994.
  • Fan, F., Wierda, D., and Rozman, K. K.,Effects of 2,3,7,8-tetrachlorodibenzo-p-di-oxin on humoral and cell-mediated immu- nity in Sprague-Dawley rats, Toxicology, 106, 221, 1996.
  • Neubert, D., Wiesmueller, T., Abraham, K., Krowke, R., and Hegenmaier, H., Persistence of various polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) in hepatic and adi- pose tissue of marmoset monkeys, Arch. Toxicol., 64, 431, 1990.
  • Neubert, R., Golor, G., Maskow, L., Helge, H., and Neubert, D., Evaluation of possible effects of 2,3,7,8-tetrachloro- dibenzo-p-dioxin and other congeners on lymphocyte receptor Callithix jacchus and man, Exp. Clin. Immunogenet., 11, 119, 1994.
  • Roegner, R. H., Grubbs, W. D., Wolfe,W. H., and Michalek, J. E., An epidemio- logic investigation of health effects in air force personnel following exposure to her- bicides, in Air Force Health Study, Vol. 6, Epidemiology Research Division, Arm- strong Laboratory, Brooks Air Force Base, TX, 1991.
  • Wolfe, W. H., Michalek, J. E., Miner, J. C., Henriksen, G. L., and Swaby, J. A., Air Force Health Study: An epidemiologic investigation of health effects of air force personnel following exposure to herbicides, Vol. 2, Epidemiologic Research Division, Brooks Air Force Base, Texas, 1995.
  • Tonn, T., Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodi- benzo-p-dioxin, Environ. Health Perspect., 104, 422, 1996.
  • Dewailly, E., Ayotte, P., Bruneau, S., Laliberte, C., and Muir, D. C. G., Inuit exposure of organochlorines through the aquatic food chain in Arctic Quebec, Environ. Health Perspect., 101, 618, 1993.
  • Weisglas-Kuperus, N., Sas, T. C. J., Koopman-Esseboom, C., van der Zwan,C. W., de Ridder, M. A. J., Beishuizen, A., Hooijkaas, H., and Sauer, P. J. J., Immunologic effects of background prena- tal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants, Pediatr. Res. ,38, 404, 1995.
  • Leatherland, J. F., Field observations on reproductive and developmental dysfunc- tion in introduced and native salmonids from the Great Lakes, J. Great Lakes Res., 19, 737, 1994.
  • Vanderpump, M. P., Tunbridge, W. M., and French, J. M., The incidence of thy- roid disorders in the community: A twenty- year follow-up of the Whickham survey, Clin. Endocrinol., 45, 55, 1995.
  • Robbins, S. L. and Kumar, V., Basic Pathology, 4th ed., W. B. Saunders Co., Philadelphia, 1987, 684.
  • Gaitan, E., Goitrogens in food and water, Ann. Rev. Nutr., 10, 21, 1990.
  • Osman, B. A., Ng, M. L., Bakar, A. A., and Khalid, B. A., The effect of cassava leave intake on thyroid hormone and uri- nary iodine, East Afr. Med. J., 70, 314, 1993.
  • Meyer, J. D., Gaitan, E., Merino, H., and Derouen, T. A., Geologic implications in the distribution of endemic goiter in Co- lombia, South America, Int. J. Epidemiol., 7, 25, 1978.
  • Gaitan, E., Merino, H., Rodriguez, G., Medina, P., Meyer, J. D., Derouen, T. A., and Maclennan, R., Epidemiology of en- demic goitre in western Colombia, Bull. WHO, 56, 403, 1978.
  • Malamos, B., Koutras, D. A., Rigopoulos, G. A., Papapetrou, P. D., Gougas, E., Kelperi, H., Moraitopoulos, C., Davi, E., and Leonardopoulos, J., Endemic goiter in Greece: some new epidemiologic stud- ies, J. Clin. Endocrin., 32, 130, 1971.
  • Vought, R. L., London, W. T., and Stebbing, G. E. T., Endemic goiter in northern Virginia, J. Clin. Endocrinol. Metab., 27, 1381, 1967.
  • Vought, R. L., Brown, F. A., and Sibinovic, K. H., Antithyroid compounds produced by Escherichia coli: Preliminary report., J. Clin. Endocrinol. Metab., 38, 861, 1974.
  • Gaitan, E., Cooksey, R. C., Legan, J., Cruse, J. M., Lindsay, R. H., and Hill, J., Antithyroid and goitrogenic effects of coal- water extracts from iodine-sufficient goiter areas, Thyroid. Spring, 3, 49, 1993.
  • McClain, R. M., Thyroid gland neoplasia: Non-genotoxic mechanisms, Toxicol. Let., 64, 397, 1992.
  • Capen, C. C., Pathophysiology of chemi- cal injury of the thyroid gland, Toxicol. Lett., 64–65, 381, 1992.
  • Dohler, K. D., Wong, C. C., and von Zur Muhlen, A., The rat as a model for the study of drug effects on thyroid function: Consideration of methodological problems, Pharmacol. Ther., 5, 305, 1979.
  • Pluim, H. J., DeVijlder, J. J. M., Loie, K., Kok, J. H., Vulsma, T., Vantijn, D. A., Van der Slikke, J. W., and Koppe, J. G., Effects of pre- and postnatal exposure to chlorinated dioxins and furans on human neonatal thyroid hormone concentrations, Environ. Health Perspect., 101, 504, 1993.
  • Murai, K., Okamura, K., and Tsuji, H., Thyroid function in Yusho patients exposed to polychlorinated biphenyls (PCB), Environ. Res., 44, 179, 1987.
  • Bastomsky, C. H., Enhanced thyroxine metabolism and high uptake goiters after a single dose of 2,3,7,8–TCDD, Endocrinol- ogy, 101, 292, 1977a.
  • Bastomsky, C. H., Goiters in rats fed poly- chlorinated biphenyls, Can. J. Physiol. Pharmacol., 55, 288, 1977b.
  • Arnold, D. L., Bryce, F., and Stapley, R., Toxicological consequences of Aroclor 1254 ingestion by female rhesus (Macaca mulatta) monkeys, Part 1A, Prebreeding phase: Clinical health findings, Food Chem. Toxicol., 31, 811, 1993.
  • Tryphonas, L., Carboneau, S., Tryphonas, H., and Zawidzka, Z., Comparative as- pects of Arochlor 1254 toxicity in adult cynomologus and rhesus monkeys: a pilot study, Arch. Environ. Contam. Toxicol., 15, 159, 1986a.
  • Tryphonas, L., Arnold, D. L., and Zawldzka, Z., A pilot study in adult rhesus monkeys (M. mulatta) treated with Aroclor 1254 for two years, Toxicol. Pathol., 14, 1, 1986b.
  • Zober, A., Ott, M. G., and Messerer, P., Morbidity follow-up study of BASF em- ployees exposed to 2,3,7,8-tetrachloro- dibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident, Occup. Environ. Med., 51, 479, 1994.
  • Seo, B-W, Li, M-H, Hansen, L. G., Moore, R. W., Peterson, R. E., and Schantz, S. L., Effects of gestational and lactational exposure to coplanar poly- chlorinated biphenyl (PCB) congeners or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thyroid hormone concentra- tions in weanling rats, Toxicol. Lett., 78, 253, 1995.
  • Juarez De Ku, L. M., Sharma-Stokker- mans, M., and Meserve, L. A., Thyroxine normalizes polychlorinated biphenyls (PCB) dose-related depression of chlorine acetyltransferase (ChAT) activity in hippocampus and basal forebrain of 15-day-old rats, Toxicology, 94, 19, 1994.
  • Ness, D. K., Schantz, S. L., Moshtaghian, J., and Hansen, L. G., Effects of prenatal exposure to specific PCB congeners on thyroid hormone concentrations and thy- roid histology in the rat, Toxicol. Lett., 68, 311, 1993.
  • Lans, M. C., Brouwer, A., Koppe, J. G., and Vandenberg, M., Enzyme induction and alterations in thyroid hormone, vita- min A and K levels by TCDD in neonatal and maternal rats, Chemosphere, 20, 1129, 1990.
  • Morse, D. C., Koester, H. B. W. M., Smits van Prooijen, A. E., and Brouwer, A., Interference of PCBs in thyroid hormone metabolism: Possibile neurotoxic conse- quences in fetal and neonatal rats, Chemo- sphere, 25, 165, 1992.
  • Bastomsky, C. H., Murthy, P. V. N., and Banovac, K., Endocrinol., 98, 1309, 1976.
  • Lans, M. C., Spiertz, C., Brouwer, A., and Koeman, J. H., Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy- PCBs, PCDDs and PCDFs, Eur. J. Pharmacol., 270, 129, 1994.
  • Bastomsky, C. H., Effects of a polychlo- rinated biphenyl mixture and DDT on bil- iary thyroxine excretion in rats, Endocri- nology, 95, 1150, 1974.
  • Zhou, L. X., Dehal, S. S., Kupfer, D., Morrell, S., McKenzie, B. A., Eccleston E. D., Jr., and Holtzman, J. L., Cyto- chrome P540 catalyzed covalent binding of methoxychlor to rat hepatic microsomal iodothyronine 5’-monodeiodinase, Type I: Does exposure to methoxyclor disrupt thy- roid hormone metabolism?, Arch. Biochem. Biophysics, 322, 390, 1995.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.